Transducing Hedgehog signals across the plasma membrane
跨质膜转导 Hedgehog 信号
基本信息
- 批准号:10642913
- 负责人:
- 金额:$ 42.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptedAffinity ChromatographyBindingBiochemicalBiochemistryBiologicalBiological AssayCancer EtiologyCell MaintenanceCell membraneCellsCellular biologyChemicalsCholesterolCongenital AbnormalityCryoelectron MicroscopyCytoplasmDevelopmentEmbryonic DevelopmentEnsureErinaceidaeEventExtracellular DomainFatty AcidsG-Protein-Coupled ReceptorsHealthHeterotrimeric GTP-Binding ProteinsHumanHyperactivityInterphase CellLabelLigandsLipidsMalignant NeoplasmsMapsMass Spectrum AnalysisMembraneMembrane ProteinsModelingMolecularMolecular ConformationMutagenesisMutationOncogenicOncoproteinsPalmitatesPathogenesisPathway interactionsProcessProteinsRoentgen RaysRoleSHH geneSignal PathwaySignal TransductionSterolsStructureTestingTransmembrane DomainTumor Suppressor ProteinsWorkX-Ray Crystallographyadult stem cellanalogcancer therapycancer typeexperimental studyhedgehog signal transductionintercellular communicationmutantnanodisknovelpatched proteinreconstitutionsmoothened signaling pathwaystructural biologytooltransmission process
项目摘要
Project summary
The Hedgehog (Hh) signaling pathway is essential for embryogenesis, for adult stem cell maintenance,
and is involved in birth defects and cancer. In the absence of stimulation, the tumor suppressor membrane
protein, Patched1 (Ptch1), inhibits the seven-spanner oncoprotein Smoothened (Smo), thus inhibiting Hh
signaling. The pathway is activated by the Sonic Hedgehog ligand (Shh), which binds and inhibits Ptch1,
allowing Smo to become active and to trigger downstream signaling events. In spite of the critical importance
of Ptch1 and Smo, their molecular mechanisms remain obscure: it is unknown how Ptch1 inhibits Smo, how
the Shh inhibits Ptch1, how Smo is activated, and how it relays signals downstream.
We recently discovered that cholesterol is the long-sought endogenous Smo activator, and that Ptch1
controls Smo via cholesterol. We solved X-ray structures of active Smo, which suggested a mechanism for
activation by cholesterol. The structures also explained the hyperactivity of a classical oncogenic Smo mutant
and pointed to a portion in Smo likely involved in downstream signaling. In preliminary work, we discovered
rapid cholesterol transfer from Smo to Ptch1, suggesting a novel mechanism for Smo inhibition by Ptch1. This
cholesterol transfer is blocked by Shh, via the novel palmitate-dependent interaction between Shh and Ptch1,
which we previously discovered, suggesting a simple mechanism for Hh pathway activation.
We propose to use biochemistry, chemical, cell and structural biology to accomplish the following aims:
A) To determine how the Ptch1 inhibits Smo, and how the Hh ligand inhibits Ptch1, to trigger Hh signaling
B) To determine precisely how cholesterol activates Smo
C) To elucidate how Smo relays Hh signals to the cytoplasm
These studies are important for the following reasons: 1) They will advance our understanding of the
Hh pathway, by deciphering critical signaling mechanisms; 2) They will clarify how Smo and Ptch1 mutations
cause cancer; 3) They will identify novel targets for blocking oncogenic Hh signaling, based on the
mechanisms of Smo and Ptch1; and 4) The novel lipid probes that we developed for studying Shh and Ptch1
will be broadly applicable beyond the Hh pathway.
项目摘要
刺猬(HH)信号通路对于胚胎发生,对于成年干细胞维持至关重要,
并参与了先天缺陷和癌症。在没有刺激的情况下,肿瘤抑制膜
蛋白质,修补1(PTCH1),抑制七氨基抗蛋白蛋白平滑(SMO),从而抑制HH
信号。该途径被Sonic刺猬配体(SHH)激活,该配体结合并抑制PTCH1,
允许SMO变得活跃并触发下游信号事件。尽管很重要
在PTCH1和SMO中,它们的分子机制仍然晦涩难懂:未知PTCH1如何抑制SMO,如何抑制如何
SHH抑制PTCH1,如何激活SMO以及如何向下游传递信号。
我们最近发现,胆固醇是长期以来的内源性SMO激活剂,并且PTCH1
通过胆固醇控制SMO。我们解决了有源SMO的X射线结构,这提出了一种机制
胆固醇激活。结构还解释了经典的致癌SMO突变体的多动症
并指出SMO中可能涉及下游信号的一部分。在初步工作中,我们发现了
从SMO到PTCH1的快速胆固醇转移,这表明PTCH1的SMO抑制作用是一种新颖的机制。这
胆固醇转移被SHH阻塞,通过SHH和PTCH1之间的新型棕榈酸酯依赖性相互作用,
我们以前发现了这一点,提出了一种简单的HH途径激活机制。
我们建议使用生物化学,化学,细胞和结构生物学来实现以下目的:
a)确定PTCH1如何抑制SMO,以及HH配体如何抑制PTCH1,以触发HH信号传导
b)精确确定胆固醇如何激活SMO
c)阐明SMO如何将HH信号传递到细胞质
由于以下原因,这些研究很重要:1)他们将提高我们对
HH途径,通过解密临界信号机制; 2)他们将阐明SMO和PTCH1突变如何
引起癌症; 3)他们将根据基于阻塞致癌HH信号的新颖目标来确定
SMO和PTCH1的机制; 4)我们开发用于研究SHH和PTCH1的新型脂质探针
将广泛适用于HH途径。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Structural insights into proteolytic activation of the human Dispatched1 transporter for Hedgehog morphogen release.
- DOI:10.1038/s41467-021-27257-w
- 发表时间:2021-11-29
- 期刊:
- 影响因子:16.6
- 作者:Li W;Wang L;Wierbowski BM;Lu M;Dong F;Liu W;Li S;Wang P;Salic A;Gong X
- 通讯作者:Gong X
Mechanism and ultrasensitivity in Hedgehog signaling revealed by Patched1 disease mutations.
Patched1 疾病突变揭示的 Hedgehog 信号传导机制和超敏感性。
- DOI:10.1073/pnas.2006800118
- 发表时间:2021
- 期刊:
- 影响因子:11.1
- 作者:Petrov,Kostadin;deAlmeidaMagalhaes,Taciani;Salic,Adrian
- 通讯作者:Salic,Adrian
Hedgehog Pathway Activation Requires Coreceptor-Catalyzed, Lipid-Dependent Relay of the Sonic Hedgehog Ligand.
- DOI:10.1016/j.devcel.2020.09.017
- 发表时间:2020-11-23
- 期刊:
- 影响因子:11.8
- 作者:Wierbowski BM;Petrov K;Aravena L;Gu G;Xu Y;Salic A
- 通讯作者:Salic A
Structural basis for catalyzed assembly of the Sonic hedgehog-Patched1 signaling complex.
- DOI:10.1016/j.devcel.2022.02.008
- 发表时间:2022-03-14
- 期刊:
- 影响因子:11.8
- 作者:Huang P;Wierbowski BM;Lian T;Chan C;García-Linares S;Jiang J;Salic A
- 通讯作者:Salic A
Distinct Cation Gradients Power Cholesterol Transport at Different Key Points in the Hedgehog Signaling Pathway.
- DOI:10.1016/j.devcel.2020.08.002
- 发表时间:2020-11-09
- 期刊:
- 影响因子:11.8
- 作者:Petrov K;Wierbowski BM;Liu J;Salic A
- 通讯作者:Salic A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ADRIAN SALIC其他文献
ADRIAN SALIC的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ADRIAN SALIC', 18)}}的其他基金
Transducing Hedgehog signals across the plasma membrane
跨质膜转导 Hedgehog 信号
- 批准号:
10251344 - 财政年份:2020
- 资助金额:
$ 42.38万 - 项目类别:
Transducing Hedgehog signals across the plasma membrane
跨质膜转导 Hedgehog 信号
- 批准号:
10434960 - 财政年份:2020
- 资助金额:
$ 42.38万 - 项目类别:
Sending and receiving Hedgehog and Wnt signals
发送和接收 Hedgehog 和 Wnt 信号
- 批准号:
10440069 - 财政年份:2018
- 资助金额:
$ 42.38万 - 项目类别:
Sending and receiving Hedgehog and Wnt signals
发送和接收 Hedgehog 和 Wnt 信号
- 批准号:
10626059 - 财政年份:2018
- 资助金额:
$ 42.38万 - 项目类别:
Sending and receiving Hedgehog and Wnt signals
发送和接收 Hedgehog 和 Wnt 信号
- 批准号:
10797274 - 财政年份:2018
- 资助金额:
$ 42.38万 - 项目类别:
Novel mechanisms for oxysterols in cell-cell signaling
氧甾醇在细胞间信号传导中的新机制
- 批准号:
9213384 - 财政年份:2014
- 资助金额:
$ 42.38万 - 项目类别:
相似国自然基金
基于亲和导向-邻近反应的复杂体系天然蛋白固定新方法及色谱评价
- 批准号:22374116
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于亲和色谱策略筛选和挖掘磷酸酶PP2A新型调节剂
- 批准号:22377149
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于仿生亲和色谱-质谱策略的肺结核患者血清抗体谱研究
- 批准号:82160027
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于亲和色谱靶点“钩钓”策略研究补肾活血方抗AGEs诱导神经损伤的作用机制
- 批准号:82104621
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
固定化单构象态受体亲和色谱的建立及止喘灵方平喘功效物质研究
- 批准号:82174088
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目
相似海外基金
Translational Regulation of SARS-CoV-2 in response to viral S protein-induced signaling
SARS-CoV-2 响应病毒 S 蛋白诱导信号传导的翻译调控
- 批准号:
10721101 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
DeADP-ribosylation of host targets mediated by a bacterial effector
由细菌效应子介导的宿主靶标的 DeADP-核糖基化
- 批准号:
10667971 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Small Molecule Probes for Fluorescence-guided Head and Neck Cancer Surgery
用于荧光引导头颈癌手术的小分子探针
- 批准号:
10644519 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Differential role of different NAD+ kinase Isoforms in melanoma metastasis
不同 NAD 激酶亚型在黑色素瘤转移中的不同作用
- 批准号:
10436014 - 财政年份:2022
- 资助金额:
$ 42.38万 - 项目类别:
Chemical instruments-aware distributed blockchain based open AI platform to accelerate drug discovery
基于化学仪器感知的分布式区块链开放人工智能平台,加速药物发现
- 批准号:
10448092 - 财政年份:2022
- 资助金额:
$ 42.38万 - 项目类别: